BodyBio, a leader in cellular health solutions, announced the launch of ReMineralize, an innovative ionic mineral supplement designed to optimize cellular function through comprehensive mineral replenishment. This groundbreaking product delivers over 72 naturally occurring trace minerals in their most bioavailable form, setting a new standard in mineral supplementation.
BD (Becton, a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.
Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the publication of a new study in the Journal of Clinical Oncology Precision Oncology. Conducted in collaboration with Japan's National Cancer Center Hospital East (NCCHE).
Centinel Spine®, LLC the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of record fourth quarter and full-year 2024 business results, positioning the Company for continued accelerated growth in 2025.
The CVS Health® Foundation announced $4 million in grants over five years as part of its new Healthy Aging initiative to support Atlanta Regional Collaborative for Health Improvement in Atlanta, GA, Center for Better Aging in Chicago, IL, EngageWell.
ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia and mixed astigmatism (a condition where both hyperopic and myopic correction is required).
Werfen announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Aptiva® Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) Reagents.
RespondHealth, a real-world evidence clinical discovery company, is pleased to announce a new integration with Microsoft to bring AI-powered solutions to the healthcare and life sciences (HLS) sectors. This collaboration integrates RespondHealth's real-world health data sources, including patient records from over 200 million Americans, with Microsoft Azure OpenAI Service, to help turn complex data into actionable insights.
Onera Health, a leader in transforming sleep medicine and remote monitoring, announced the publication of a multicenter validation study of its Onera Sleep Test System (STS) in the Journal of Clinical Sleep Medicine, the official journal of the American Academy of Sleep Medicine. The study demonstrated that the patch-based Onera STS home-polysomnography (hPSG) performs comparably to gold-standard in-lab polysomnography (PSG) for both sleep staging and respiratory event detection.
Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a Lunit company and a global leader in mammography AI for the early detection of cancer, announced their unified vision, focusing on a comprehensive Ecosystem for early cancer detection, cancer risk prediction, and autonomous AI for enhanced clinical workflows.